0000899243-18-020458.txt : 20180723 0000899243-18-020458.hdr.sgml : 20180723 20180723201559 ACCESSION NUMBER: 0000899243-18-020458 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180723 FILED AS OF DATE: 20180723 DATE AS OF CHANGE: 20180723 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: REGENTS OF THE UNIVERSITY OF CALIFORNIA CENTRAL INDEX KEY: 0000315054 STATE OF INCORPORATION: CA FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38584 FILM NUMBER: 18965448 BUSINESS ADDRESS: STREET 1: 1111 BROADWAY STREET 2: 21ST FLOOR CITY: OAKLAND STATE: CA ZIP: 94607-4026 BUSINESS PHONE: 510-987-9600 MAIL ADDRESS: STREET 1: 1111 BROADWAY STREET 2: 21ST FLOOR CITY: OAKLAND STATE: CA ZIP: 94607-4026 FORMER NAME: FORMER CONFORMED NAME: REGENTS OF THE UNIVERSITY OF CA DATE OF NAME CHANGE: 19600201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CONSTELLATION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001434418 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-714-0555 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-07-23 1 0001434418 CONSTELLATION PHARMACEUTICALS INC CNST 0000315054 REGENTS OF THE UNIVERSITY OF CALIFORNIA 1111 BROADWAY, SUITE 2100 OAKLAND CA 94607 0 0 1 0 Common Stock 2018-07-23 4 C 0 2164073 A 2164073 D Common Stock 2018-07-23 4 P 0 133333 15.00 A 2297406 D Series E Preferred Stock 2018-07-23 4 C 0 6666666 0.00 D Common Stock 778583 0 D Series E-1 Preferred Stock 2018-07-23 4 C 0 6502856 0.00 D Common Stock 590684 0 D Series F Preferred Stock 2018-07-23 4 C 0 8750000 0.00 D Common Stock 794806 0 D On July 23, 2018, the Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date. /s/ Arthur R. Guimaraes 2018-07-23